Researchers present a shift in neuro-nanomedicine, reframing the “protein corona”, the layer of blood proteins that coat nanoparticles, as a programmable, five-stage navigation interface capable of guiding therapeutics across the blood-brain barrier via receptor-mediated transcytosis.
